Skip to content
PICO Portalanswers from OpenAlex

An MN9 Antigenic Molecule, Equatorin, Is Required for Successful Sperm-Oocyte Fusion in Mice1

PaperCitations, authors & open-access status

An MN9 Antigenic Molecule, Equatorin, Is Required for Successful Sperm-Oocyte Fusion in Mice1 is a paper indexed in PICO Portal from OpenAlex.

How many citations does An MN9 Antigenic Molecule, Equatorin, Is Required for Successful Sperm-Oocyte Fusion in Mice1 have?

PICO Portalcitation count

An MN9 Antigenic Molecule, Equatorin, Is Required for Successful Sperm-Oocyte Fusion in Mice1 has 99 citations in the OpenAlex counts PICO Portal stores.

When was An MN9 Antigenic Molecule, Equatorin, Is Required for Successful Sperm-Oocyte Fusion in Mice1 published?

PICO Portalyear

An MN9 Antigenic Molecule, Equatorin, Is Required for Successful Sperm-Oocyte Fusion in Mice1 has 1998 year in the PICO Portal index.

What is the open-access status of An MN9 Antigenic Molecule, Equatorin, Is Required for Successful Sperm-Oocyte Fusion in Mice1?

PICO Portaloa status

An MN9 Antigenic Molecule, Equatorin, Is Required for Successful Sperm-Oocyte Fusion in Mice1 has closed oa status in the PICO Portal index.

What is the DOI of An MN9 Antigenic Molecule, Equatorin, Is Required for Successful Sperm-Oocyte Fusion in Mice1?

PICO Portaldoi

The DOI for An MN9 Antigenic Molecule, Equatorin, Is Required for Successful Sperm-Oocyte Fusion in Mice1 is on the source record.

What is the PMID of An MN9 Antigenic Molecule, Equatorin, Is Required for Successful Sperm-Oocyte Fusion in Mice1?

PICO Portalpmid

The PMID for An MN9 Antigenic Molecule, Equatorin, Is Required for Successful Sperm-Oocyte Fusion in Mice1 is on the source record.

What is the OpenAlex record for An MN9 Antigenic Molecule, Equatorin, Is Required for Successful Sperm-Oocyte Fusion in Mice1?

PICO Portalopenalex

The OpenAlex for An MN9 Antigenic Molecule, Equatorin, Is Required for Successful Sperm-Oocyte Fusion in Mice1 is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial